Table of Contents 1 Study Coverage 1.1 Chronic Kidney Disease (CKD) Drugs Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate by Product 1.4.2 ACE inhibitors 1.4.3 Angiotensin-II receptor blockers 1.4.4 Calcium channel blockers 1.4.5 Beta blockers: BREVIBLOC, Bystolic 1.4.6 Others 1.5 Market by End User 1.5.1 Global Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate by End User 1.5.2 Hospitals 1.5.3 Specialty Clinics 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Chronic Kidney Disease (CKD) Drugs Market Size 2.1.1 Global Chronic Kidney Disease (CKD) Drugs Revenue 2014-2025 2.1.2 Global Chronic Kidney Disease (CKD) Drugs Sales 2014-2025 2.2 Chronic Kidney Disease (CKD) Drugs Growth Rate by Regions 2.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales by Regions 2.2.2 Global Chronic Kidney Disease (CKD) Drugs Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Chronic Kidney Disease (CKD) Drugs Sales by Manufacturers 3.1.1 Chronic Kidney Disease (CKD) Drugs Sales by Manufacturers 3.1.2 Chronic Kidney Disease (CKD) Drugs Sales Market Share by Manufacturers 3.1.3 Global Chronic Kidney Disease (CKD) Drugs Market Concentration Ratio (CR5 and HHI) 3.2 Chronic Kidney Disease (CKD) Drugs Revenue by Manufacturers 3.2.1 Chronic Kidney Disease (CKD) Drugs Revenue by Manufacturers (2014-2019) 3.2.2 Chronic Kidney Disease (CKD) Drugs Revenue Share by Manufacturers (2014-2019) 3.3 Chronic Kidney Disease (CKD) Drugs Price by Manufacturers 3.4 Chronic Kidney Disease (CKD) Drugs Manufacturing Base Distribution, Product Types 3.4.1 Chronic Kidney Disease (CKD) Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Chronic Kidney Disease (CKD) Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Chronic Kidney Disease (CKD) Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Chronic Kidney Disease (CKD) Drugs Sales by Product 4.2 Global Chronic Kidney Disease (CKD) Drugs Revenue by Product 4.3 Chronic Kidney Disease (CKD) Drugs Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Chronic Kidney Disease (CKD) Drugs Breakdown Data by End User 6 North America 6.1 North America Chronic Kidney Disease (CKD) Drugs by Countries 6.1.1 North America Chronic Kidney Disease (CKD) Drugs Sales by Countries 6.1.2 North America Chronic Kidney Disease (CKD) Drugs Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Chronic Kidney Disease (CKD) Drugs by Product 6.3 North America Chronic Kidney Disease (CKD) Drugs by End User 7 Europe 7.1 Europe Chronic Kidney Disease (CKD) Drugs by Countries 7.1.1 Europe Chronic Kidney Disease (CKD) Drugs Sales by Countries 7.1.2 Europe Chronic Kidney Disease (CKD) Drugs Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Chronic Kidney Disease (CKD) Drugs by Product 7.3 Europe Chronic Kidney Disease (CKD) Drugs by End User 8 Asia Pacific 8.1 Asia Pacific Chronic Kidney Disease (CKD) Drugs by Countries 8.1.1 Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Countries 8.1.2 Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Chronic Kidney Disease (CKD) Drugs by Product 8.3 Asia Pacific Chronic Kidney Disease (CKD) Drugs by End User 9 Central & South America 9.1 Central & South America Chronic Kidney Disease (CKD) Drugs by Countries 9.1.1 Central & South America Chronic Kidney Disease (CKD) Drugs Sales by Countries 9.1.2 Central & South America Chronic Kidney Disease (CKD) Drugs Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Chronic Kidney Disease (CKD) Drugs by Product 9.3 Central & South America Chronic Kidney Disease (CKD) Drugs by End User 10 Middle East and Africa 10.1 Middle East and Africa Chronic Kidney Disease (CKD) Drugs by Countries 10.1.1 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Countries 10.1.2 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Chronic Kidney Disease (CKD) Drugs by Product 10.3 Middle East and Africa Chronic Kidney Disease (CKD) Drugs by End User 11 Company Profiles 11.1 Pfizer, Inc. 11.1.1 Pfizer, Inc. Company Details 11.1.2 Company Business Overview 11.1.3 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Products Offered 11.1.5 Pfizer, Inc. Recent Development 11.2 Amgen 11.2.1 Amgen Company Details 11.2.2 Company Business Overview 11.2.3 Amgen Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Amgen Chronic Kidney Disease (CKD) Drugs Products Offered 11.2.5 Amgen Recent Development 11.3 Roche 11.3.1 Roche Company Details 11.3.2 Company Business Overview 11.3.3 Roche Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Roche Chronic Kidney Disease (CKD) Drugs Products Offered 11.3.5 Roche Recent Development 11.4 GlaxoSmithKline (GSK) 11.4.1 GlaxoSmithKline (GSK) Company Details 11.4.2 Company Business Overview 11.4.3 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2014-2019) 11.4.4 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Products Offered 11.4.5 GlaxoSmithKline (GSK) Recent Development 11.5 Allergan 11.5.1 Allergan Company Details 11.5.2 Company Business Overview 11.5.3 Allergan Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2014-2019) 11.5.4 Allergan Chronic Kidney Disease (CKD) Drugs Products Offered 11.5.5 Allergan Recent Development 11.6 AbbVie 11.6.1 AbbVie Company Details 11.6.2 Company Business Overview 11.6.3 AbbVie Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2014-2019) 11.6.4 AbbVie Chronic Kidney Disease (CKD) Drugs Products Offered 11.6.5 AbbVie Recent Development 11.7 Kissei Pharmaceutical Co., Ltd. 11.7.1 Kissei Pharmaceutical Co., Ltd. Company Details 11.7.2 Company Business Overview 11.7.3 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Products Offered 11.7.5 Kissei Pharmaceutical Co., Ltd. Recent Development 12 Future Forecast 12.1 Chronic Kidney Disease (CKD) Drugs Market Forecast by Regions 12.1.1 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Regions 2019-2025 12.1.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Regions 2019-2025 12.2 Chronic Kidney Disease (CKD) Drugs Market Forecast by Product 12.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Product 2019-2025 12.2.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Product 2019-2025 12.3 Chronic Kidney Disease (CKD) Drugs Market Forecast by End User 12.4 North America Chronic Kidney Disease (CKD) Drugs Forecast 12.5 Europe Chronic Kidney Disease (CKD) Drugs Forecast 12.6 Asia Pacific Chronic Kidney Disease (CKD) Drugs Forecast 12.7 Central & South America Chronic Kidney Disease (CKD) Drugs Forecast 12.8 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Chronic Kidney Disease (CKD) Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Chronic Kidney Disease (CKD) Drugs Product Picture Table Chronic Kidney Disease (CKD) Drugs Market Segments Table Key Manufacturers Chronic Kidney Disease (CKD) Drugs Covered Table Global Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Product 2014-2025 Figure ACE inhibitors Product Picture Table Major Manufacturers of ACE inhibitors Figure Angiotensin-II receptor blockers Product Picture Table Major Manufacturers of Angiotensin-II receptor blockers Figure Calcium channel blockers Product Picture Table Major Manufacturers of Calcium channel blockers Figure Beta blockers: BREVIBLOC, Bystolic Product Picture Table Major Manufacturers of Beta blockers: BREVIBLOC, Bystolic Figure Others Product Picture Table Major Manufacturers of Others Table Global Chronic Kidney Disease (CKD) Drugs Market Size Growth Rate by End User 2019-2025 (K Units) Figure Hospitals Figure Specialty Clinics Figure Chronic Kidney Disease (CKD) Drugs Report Years Considered Figure Global Chronic Kidney Disease (CKD) Drugs Market Size 2014-2025 (Million US$) Figure Global Chronic Kidney Disease (CKD) Drugs Sales 2014-2025 (K Units) Table Global Chronic Kidney Disease (CKD) Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Chronic Kidney Disease (CKD) Drugs Sales by Regions 2014-2019 (K Units) Table Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Regions 2014-2019 Figure Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Regions 2014-2019 Figure 2018 Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Regions Table Global Chronic Kidney Disease (CKD) Drugs Revenue by Regions 2014-2019 (Million US$) Table Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Regions 2014-2019 Figure Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Regions 2014-2019 Figure 2018 Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Regions Table Global Chronic Kidney Disease (CKD) Drugs Sales by Manufacturers (2014-2019) (K Units) Table Global Chronic Kidney Disease (CKD) Drugs Sales Share by Manufacturers (2014-2019) Figure Global Chronic Kidney Disease (CKD) Drugs Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Chronic Kidney Disease (CKD) Drugs Revenue by Manufacturers (2014-2019) (Million USD) Table Chronic Kidney Disease (CKD) Drugs Revenue Share by Manufacturers (2014-2019) Figure Chronic Kidney Disease (CKD) Drugs Value Share by Manufacturers in 2018 Table Key Manufacturers Chronic Kidney Disease (CKD) Drugs Price (2014-2019) (USD/Unit) Table Chronic Kidney Disease (CKD) Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Chronic Kidney Disease (CKD) Drugs Product Type Table Date of International Manufacturers Enter into Chronic Kidney Disease (CKD) Drugs Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Chronic Kidney Disease (CKD) Drugs Sales by Product (2014-2019) (K Units) Table Global Chronic Kidney Disease (CKD) Drugs Sales Share by Product (2014-2019) Figure Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Product (2014-2019) Figure Global Chronic Kidney Disease (CKD) Drugs Sales Market Share by Product in 2018 Table Global Chronic Kidney Disease (CKD) Drugs Revenue by Product (2014-2019) (Million US$) Table Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Product (2014-2019) Figure Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Product (2014-2019) Figure Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Product in 2018 Table Chronic Kidney Disease (CKD) Drugs Price by Product 2014-2019 (USD/Unit) Table Global Chronic Kidney Disease (CKD) Drugs Sales by End User (2014-2019) (K Units) Table Global Chronic Kidney Disease (CKD) Drugs Sales Share by End User (2014-2019) Figure Global Sales Chronic Kidney Disease (CKD) Drugs Market Share by End User (2014-2019) Figure Global Sales Chronic Kidney Disease (CKD) Drugs Market Share by End User in 2018 Figure North America Chronic Kidney Disease (CKD) Drugs Sales Growth Rate 2014-2019 (K Units) Figure North America Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate 2014-2019 (Million US$) Table North America Chronic Kidney Disease (CKD) Drugs Sales by Countries (2014-2019) (K Units) Table North America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries (2014-2019) Figure 2018 North America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries Table North America Chronic Kidney Disease (CKD) Drugs Revenue by Countries (2014-2019) (Million US$) Table North America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 North America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries Figure United States Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure United States Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (K Units) Figure Canada Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Canada Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Mexico Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Table North America Chronic Kidney Disease (CKD) Drugs Sales by Product (2014-2019) (K Units) Table North America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Product (2014-2019) Figure 2018 North America Chronic Kidney Disease (CKD) Drugs Market Share by Product Table North America Chronic Kidney Disease (CKD) Drugs Sales by End User (2014-2019) (K Units) Table North America Chronic Kidney Disease (CKD) Drugs Sales Market Share by End User (2014-2019) Figure 2018 North America Chronic Kidney Disease (CKD) Drugs Market Share by End User Figure Europe Chronic Kidney Disease (CKD) Drugs Sales Growth Rate 2014-2019 (K Units) Figure Europe Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Europe Chronic Kidney Disease (CKD) Drugs Sales by Countries (2014-2019) (K Units) Table Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries Table Europe Chronic Kidney Disease (CKD) Drugs Revenue by Countries (2014-2019) (Million US$) Table Europe Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries Figure Germany Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Germany Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure France Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure France Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure UK Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure UK Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Italy Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Russia Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Europe Chronic Kidney Disease (CKD) Drugs Sales by Product (2014-2019) (K Units) Table Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share by Product (2014-2019) Figure 2018 Europe Chronic Kidney Disease (CKD) Drugs Market Share by Product Table Europe Chronic Kidney Disease (CKD) Drugs Sales by End User (2014-2019) (K Units) Table Europe Chronic Kidney Disease (CKD) Drugs Sales Market Share by End User (2014-2019) Figure 2018 Europe Chronic Kidney Disease (CKD) Drugs Market Share by End User Figure Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Countries (2014-2019) (K Units) Table Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries Table Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries Figure China Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure China Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Japan Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Korea Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure India Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure India Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Australia Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Philippines Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Thailand Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Singapore Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by Product (2014-2019) (K Units) Table Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Share by Product Table Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales by End User (2014-2019) (K Units) Table Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Chronic Kidney Disease (CKD) Drugs Market Share by End User Figure Central & South America Chronic Kidney Disease (CKD) Drugs Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Chronic Kidney Disease (CKD) Drugs Sales by Countries (2014-2019) (K Units) Table Central & South America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries Table Central & South America Chronic Kidney Disease (CKD) Drugs Revenue by Countries (2014-2019) (Million US$) Table Central & South America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries Figure Brazil Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Brazil Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Argentina Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Chronic Kidney Disease (CKD) Drugs Sales by Product (2014-2019) (K Units) Table Central & South America Chronic Kidney Disease (CKD) Drugs Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Chronic Kidney Disease (CKD) Drugs Market Share by Product Table Central & South America Chronic Kidney Disease (CKD) Drugs Sales by End User (2014-2019) (K Units) Table Central & South America Chronic Kidney Disease (CKD) Drugs Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Chronic Kidney Disease (CKD) Drugs Market Share by End User Figure Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Countries (2014-2019) (K Units) Table Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share by Countries Table Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Countries Figure GCC Countries Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Turkey Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure Egypt Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Chronic Kidney Disease (CKD) Drugs Sales Growth Rate (2014-2019) (K Units) Figure South Africa Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by Product (2014-2019) (K Units) Table Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Share by Product Table Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales by End User (2014-2019) (K Units) Table Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Chronic Kidney Disease (CKD) Drugs Market Share by End User Table Pfizer, Inc. Company Details Table Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer, Inc. Recent Development Table Amgen Company Details Table Amgen Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Amgen Recent Development Table Roche Company Details Table Roche Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Roche Recent Development Table GlaxoSmithKline (GSK) Company Details Table GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table GlaxoSmithKline (GSK) Recent Development Table Allergan Company Details Table Allergan Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Allergan Recent Development Table AbbVie Company Details Table AbbVie Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table AbbVie Recent Development Table Kissei Pharmaceutical Co., Ltd. Company Details Table Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Kissei Pharmaceutical Co., Ltd. Recent Development Table Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Regions 2019-2025 (K Units) Table Global Chronic Kidney Disease (CKD) Drugs Sales Market Share Forecast by Regions 2019-2025 Table Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share Forecast by Regions 2019-2025 Table Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by Product 2019-2025 (K Units) Table Global Chronic Kidney Disease (CKD) Drugs Sales Market Share Forecast by Product 2019-2025 Table Global Chronic Kidney Disease (CKD) Drugs Revenue Forecast by Product 2019-2025 (Million US$) Table Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share Forecast by Product 2019-2025 Table Global Chronic Kidney Disease (CKD) Drugs Sales Forecast by End User 2019-2025 (K Units) Table Global Chronic Kidney Disease (CKD) Drugs Sales Market Share Forecast by End User 2019-2025 Figure North America Chronic Kidney Disease (CKD) Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Chronic Kidney Disease (CKD) Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Chronic Kidney Disease (CKD) Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Chronic Kidney Disease (CKD) Drugs Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Chronic Kidney Disease (CKD) Drugs Value Chain Table Chronic Kidney Disease (CKD) Drugs Customers List Table Chronic Kidney Disease (CKD) Drugs Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Pfizer, Inc. Amgen Roche GlaxoSmithKline (GSK) Allergan AbbVie Kissei Pharmaceutical Co., Ltd.